Rho GTPase signaling and PTH 3-34, but not PTH 1-34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells

Nikolas H. Kazmers, Sophia A. Ma, Tomohiko Yoshida, Paula H. Stern*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Cytoskeletal elements are critical for cell morphology and signal transduction, and are involved in many cellular processes including motility, intracellular transport, and differentiation. Small GTP-binding proteins (G proteins) of the Ras family, such as RhoA, influence various elements of the cytoskeleton. RhoA stabilizes the actin cytoskeleton and promotes formation of focal adhesions. We found previously that RhoA is expressed in osteoblastic cells and is translocated to the plasma membrane and activated by PTH 1-34 as well as by Nleu8,18 Tyr34 PTH 3-34 amide, a PTH analog that does not increase cAMP. We therefore investigated effects of manipulating RhoA on the actin cytoskeleton of osteoblastic MC3T3-E1 cells. Three inhibitors were used: 1) GGTI-2166, a geranylgeranyl transferase I inhibitor that prevents the isoprenylation and membrane translocation of RhoA, 2) Y-27632, a Rho kinase inhibitor, and 3) alendronate, a nitrogen (N)-containing bisphosphonate that reduces intracellular geranylgeranylpyrophosphate through inhibiting farnesyl pyrophosphate synthase. To increase RhoA activity, we used the geranylgeranyl group donor geranylgeraniol (GGOH), and a constitutively active RhoA. The F-actin cytoskeleton and focal adhesions (FA) were visualized with rhodamine-phalloidin and fluorescent anti-vinculin antibodies, respectively. Cells were imaged with confocal microscopy. Actin stress fiber density, edge actin bundle density, focal adhesion density, cellular area and circularity (a morphological descriptor relating area and perimeter) were quantified by a program developed with Matlab® software. GGTI-2166, Y-27632, and alendronate reduced actin stress fibers, FA density, and FA size, but had no effect on edge actin bundle density, cellular area, or circularity. GGOH completely antagonized the effects of alendronate, but did not significantly affect responses to GGTI-2166 or Y-27632. Constitutively active RhoA antagonized the effects of alendronate and GGTI-2166, but not those of Y-27632. The effects of alendronate were also antagonized by Nleu8,18 Tyr34 PTH 3-34 amide, but not by PTH 1-34. The results indicate that RhoA is involved in the maintenance of stress fibers and focal adhesions in osteoblastic cells, that PTH can affect this pathway independently of cAMP, and that a N-containing bisphosphonate can affect the actin cytoskeleton and focal adhesions through actions on geranylgeranyl groups and potentially through RhoA. In view of the importance of the actin cytoskeleton, the findings constitute evidence that N-containing bisphosphonates, when they attain certain concentrations, have effects on osteoblasts that could influence bone remodeling.

Original languageEnglish (US)
Pages (from-to)52-60
Number of pages9
JournalBone
Volume45
Issue number1
DOIs
StatePublished - Jul 2009

Funding

This study was supported by NIH grant AR11262 to PHS. The Medical Student Summer Research Program of Northwestern University's Feinberg School of Medicine provided stipend support for Nikolas H. Kazmers. Dr. Said Sebti, Moffitt Cancer Center and Research Institute and Andrew Hamilton, Yale University kindly donated the GGTI-2166 reagent and Dr Sebti also provided the constitutively active RhoA plasmid. Dr. Alfred Reszka, Merck Research Laboratories, kindly donated the alendronate. We thank Dr. Richard Miller for his generosity in granting us time in his confocal microscopy facility, Dr. Jun Wang for the preparation of the RhoA plasmid for transfection, and for his helpful input, Zhendong Hong, Dongjun Ren, Philip Hockberger and James Bartles for helpful discussions, and Shirley Foster for her input in the laboratory. Some of the findings in this manuscript were reported at the American Society for Bone and Mineral Research meeting on Targeting Bone Remodeling for the Treatment of Osteoporosis, December 2007.

Keywords

  • Bisphosphonate
  • Cytoskeleton
  • Osteoblast
  • Parathyroid hormone
  • RhoA

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Fingerprint

Dive into the research topics of 'Rho GTPase signaling and PTH 3-34, but not PTH 1-34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells'. Together they form a unique fingerprint.

Cite this